Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

PHASE2CompletedINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

Not specified

Primary Completion Date

February 28, 2002

Conditions
HIV InfectionsLipodystrophy
Interventions
DRUG

Abacavir sulfate, Lamivudine and Zidovudine

DRUG

Abacavir sulfate

DRUG

Efavirenz

DRUG

Nevirapine

Trial Locations (11)

10003

Beth Israel Med Ctr, New York

10016

Bellevue Hosp / New York Univ Med Ctr, New York

15213

Univ of Pittsburgh, Pittsburgh

19104

Univ of Pennsylvania, Philadelphia

20007

Georgetown Univ Med Ctr, Washington D.C.

30308

Emory Univ, Atlanta

35294

Univ of Alabama at Birmingham, Birmingham

60611

Northwestern Univ Med School, Chicago

60612

The CORE Ctr, Chicago

02118

Boston Med Ctr, Boston

02215

Brigham and Women's Hosp, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH